The Rotherham NHS Foundation Trust

South Yorkshire and Bassetlaw, Cancer Alliance

Management of High Grade Dysplasia patients

Time period: 2015-19
Cancer Alliance National
Number of High Grade Dysplasia patients in audit 60 1448
Cancer Alliance National
Method of Diagnosis
– First diagnosis confirmed by second pathologist 58 96.6% 86.9%
Treatment planning
– HGD plan discussed at MDT 57 95.0% 87.9%
– Treatment plan for active treatment 54 90.0% 81.1%
First treatment
– Endoscopic therapy (such as endoscopic resection) 48 80.0% 73.8%
– Surveillance 2 3.3% 11.0%

Management of oesophago-gastric cancer patients

Time period: 2017-2019
Organisation National
Number of oesophago-gastric (OG) cancer patients in audit 97 20528
Case ascertainment for OG cancer (%) 85-100%
Method of Diagnosis
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations
14 13.9% 13.3%
– Patients with referral source reported as unknown 0 0.0% 1.8%
Pre-treatment staging of cancer
– Patients having staging CT scan recorded 97 100.0% 86.9%
Treatment planning
– Patients having a plan for curative treatment 27 27.8% 38.5%
– Patients having a plan for non-curative treatment 70 72.2% 61.5%
– Patients with non-curative plans having chemotherapy or radiotherapy 33 47.1% 48.2%

Download this data as a PDF